Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Lucid Group Inc (LCID) vs Neurocrine Biosciences Inc (NBIX) Price & Performance

Lucid Group IncTrade
Neurocrine Biosciences IncTrade

Price performance (Past 24H)

Key statistics

Lucid Group Inc vs Neurocrine Biosciences Inc — how do they compare? Lucid Group Inc trades at $6.69 (market cap $2.64B), while Neurocrine Biosciences Inc trades at $151.75 (market cap $16.46B). The key difference: Neurocrine Biosciences Inc is far larger — about 6.2× Lucid Group Inc's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Lucid Group Inc nearer its low. Which is the better fit depends on your goals.

LCIDNBIX
Market Cap
$2.64B$16.46B
Sector
Consumer CyclicalHealth
52-Week High
$24.77$185.50
52-Week Low
$4.62$123.10
Enterprise Value
$5.54B$16.48B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Lucid Group Inc

Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It is a vertically integrated company that designs, engineers, and builds electric vehicles, EV powertrains, and battery systems in-house using our own equipment and factory.

Read more on LCID

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.

Read more on NBIX